Catalyst Wire Dossier Catalyst Wire Dossier

Interferon alfa-5

interferon alfa-5 · Digna Biotech S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interferon alfa-5, covering 2013-02-05 to 2013-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C [Phase 1, Phase 2]

See pricing